Global Heart Implants Market Research Report 2022
Heart Implants (or Cardiac Implants) are used to monitor the heart to maintain its normal functions. Cardiac Implants will record the condition of the heart and detect the fluctuations and provide this information to the Doctor and Health care provider.
Due to the COVID-19 pandemic, the global Heart Implants market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Heart Implants market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Heart Implants landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The heart implants market is expected to grow exponentially during the forecast period, primarily due to the changing lifestyle, fatal accidents, physical inactivity and prognosis of patients with heart failure leading to end-stage cardiac disorder are some of the key drivers of this market. High prevalence of cardiac disorders among middle class population is another significant driver for heart implants market. Though the market seems optimistic in coming years, shifting trends from heart-beating donations to non-heart beating procedures, high costs of devices along with stringent regulatory procedures in some of the key nations can led to some negative impact on this industry. However, this billion dollar industry is expected to witness upward trend during the forecast period 2015–2025, primarily due to rise in demand for heart implants.
This report focuses on Heart Implants volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Heart Implants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Heart Implants Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Cardiac Rhythm Management Devices
Coronary Stent Devices
Prosthetic Heart Valves
Cardiac Assist Devices
Segment by Application
Arrhythmias
Myocardial Ischemia
Acute Myocardial Infarction
Congestive Heart Failure
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic, Inc.
Boston Scientific Corporation
Abbott Vascular Inc.
Edwards Life-sciences Corporation.
Abbott
Thoratec Corporation
SynCardia Systems, Inc.
Terumo (ESSEN)
Lepu Medical
MicroPort
Biosensors
B.Braun
Biotronik
SINOMED
Due to the COVID-19 pandemic, the global Heart Implants market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Heart Implants market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Heart Implants landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The heart implants market is expected to grow exponentially during the forecast period, primarily due to the changing lifestyle, fatal accidents, physical inactivity and prognosis of patients with heart failure leading to end-stage cardiac disorder are some of the key drivers of this market. High prevalence of cardiac disorders among middle class population is another significant driver for heart implants market. Though the market seems optimistic in coming years, shifting trends from heart-beating donations to non-heart beating procedures, high costs of devices along with stringent regulatory procedures in some of the key nations can led to some negative impact on this industry. However, this billion dollar industry is expected to witness upward trend during the forecast period 2015–2025, primarily due to rise in demand for heart implants.
This report focuses on Heart Implants volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Heart Implants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Heart Implants Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Cardiac Rhythm Management Devices
Coronary Stent Devices
Prosthetic Heart Valves
Cardiac Assist Devices
Segment by Application
Arrhythmias
Myocardial Ischemia
Acute Myocardial Infarction
Congestive Heart Failure
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Medtronic, Inc.
Boston Scientific Corporation
Abbott Vascular Inc.
Edwards Life-sciences Corporation.
Abbott
Thoratec Corporation
SynCardia Systems, Inc.
Terumo (ESSEN)
Lepu Medical
MicroPort
Biosensors
B.Braun
Biotronik
SINOMED
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
